info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Prostate Cancer

    Prostate Cancer Products

    Discover a wide range of Prostate Cancer products under the Oncology category. Allieva Pharma provides high-quality pharmaceutical solutions trusted across India and global markets.

    ENZALIEVA 160MG Enzalutamide Tablets 160mg by ENZALIEVA 160MG

    ENZALIEVA 160MG

    Enzalutamide Tablets 160mg

    ENZALIEVA Enzalutamide Tablets 160mg is an advanced anticancer medicine used for the treatment of prostate cancer in adult patients. It contains Enzalutamide, a powerful androgen receptor inhibitor that helps slow down the growth and spread of prostate cancer cells. This medicine is commonly prescribed by oncologists as part of hormone therapy for patients suffering from advanced or metastatic prostate cancer. Prostate cancer is one of the most common cancers affecting men worldwide. Cancer cells in the prostate often depend on male hormones called androgens, especially testosterone, for growth and survival. Enzalutamide works by blocking the action of these hormones, helping reduce the ability of cancer cells to grow and multiply. Due to its targeted mechanism of action, ENZALIEVA is widely used in modern oncology treatment protocols for prostate cancer management. ENZALIEVA Enzalutamide Tablets 160mg is manufactured under strict pharmaceutical quality standards to ensure safety, effectiveness, and consistent therapeutic performance. The medicine is commonly recommended in patients with: Metastatic castration-resistant prostate cancer (mCRPC) Non-metastatic castration-resistant prostate cancer (nmCRPC) Metastatic hormone-sensitive prostate cancer (mHSPC) This anticancer medicine is usually prescribed when prostate cancer continues to progress despite reduced testosterone levels or hormonal treatment. Doctors may use ENZALIEVA alone or in combination with other therapies depending on the patient’s condition, cancer stage, and overall treatment plan. Enzalutamide Tablets are known for helping improve disease management by delaying cancer progression and supporting overall treatment outcomes. The medicine has become an important part of prostate cancer therapy due to its effectiveness in controlling androgen receptor activity, which plays a major role in prostate cancer growth. Patients should use this medicine strictly under the supervision of qualified healthcare professionals. Proper medical monitoring and regular health checkups are important during treatment to ensure better response and patient safety.

    View Details
    BICALIEVA 50MG Bicalutamide Tablet IP 50mg by BICALIEVA 50MG

    BICALIEVA 50MG

    Bicalutamide Tablet IP 50mg

    BICALIEVA contains Bicalutamide, a non-steroidal anti-androgen. It works by blocking androgen receptors, preventing testosterone from stimulating prostate cancer cell growth.

    View Details
    ABIRALIEVA 500MG Abiraterone Acetate Tablets IP 500mg by ABIRALIEVA 500MG

    ABIRALIEVA 500MG

    Abiraterone Acetate Tablets IP 500mg

    ABIRALIEVA 500 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It blocks the enzyme CYP17 (17α-hydroxylase/17,20-lyase), which is essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This results in profound suppression of circulating and intratumoral androgens, slowing prostate cancer growth.

    View Details
    ABIRALIEVA 250MG Abiraterone Acetate Tablets IP 25mg by ABIRALIEVA 250MG

    ABIRALIEVA 250MG

    Abiraterone Acetate Tablets IP 25mg

    ABIRALIEVA 250 mg contains Abiraterone Acetate, an oral androgen biosynthesis inhibitor. It works by irreversibly inhibiting CYP17 (17α-hydroxylase/17,20-lyase), an enzyme essential for androgen production in the testes, adrenal glands, and prostate tumor tissue. This leads to profound suppression of androgen levels and slows prostate cancer progression.

    View Details
    ENZALIEVA 40MG Enzalutamide Capsules 40mg by ENZALIEVA 40MG

    ENZALIEVA 40MG

    Enzalutamide Capsules 40mg

    ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.

    View Details
    ENZALIEVA 40MG Enzalutamide Capsules 40mg by ENZALIEVA 40MG

    ENZALIEVA 40MG

    Enzalutamide Capsules 40mg

    ENZALIEVA 40 mg contains Enzalutamide, an oral androgen receptor (AR) inhibitor. It works by blocking androgen receptor signaling at multiple steps—preventing androgen binding, nuclear translocation, and DNA interaction—thereby inhibiting prostate cancer cell growth.

    View Details
    • 1

    24/7 Clients Support

    Best Price

    Quality Assurance